ATRA · Company research
Atara Biotherapeutics, Inc (ATRA): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
17records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Atara Biotherapeutics Inc (ATRA) Stock Price, Trades & News - GuruFocus | Atara Biotherapeutics Inc (ATRA) Stock Price, Trades & News GuruFocus | View source ↗ | GuruFocus | Oct 7, 2026 | neutral | 0 | 0.6 |
| Precision Trading with Atara Biotherapeutics Inc. (ATRA) Risk Zones - Stock Traders Daily | Precision Trading with Atara Biotherapeutics Inc. (ATRA) Risk Zones Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 5, 2026 | neutral | 0 | 0.6 |
| Atara Biotherapeutics (ATRA) Slides 3.82% to $8.05 as Shares Drift Toward Lower Support - Swing Entry Signals - https://www.siam.in/ | Atara Biotherapeutics (ATRA) Slides 3.82% to $8.05 as Shares Drift Toward Lower Support - Swing Entry Signals https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Sep 29, 2026 | neutral | 0 | 0.6 |
| Insider Purchase: Director at $ATRA Buys 104,166 Shares - Quiver Quantitative | Insider Purchase: Director at $ATRA Buys 104,166 Shares Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 8, 2026 | neutral | 0 | 0.6 |
| Atara Biotherapeutics (ATRA) employee plans 5,062-share tax sale - Stock Titan | Atara Biotherapeutics (ATRA) employee plans 5,062-share tax sale Stock Titan | View source ↗ | Stock Titan | Aug 26, 2026 | neutral | 0 | 0.6 |
| Atara Biotherapeutics (ATRA) Inches Higher as Shares Test Key Resistance - Institutional Volume - po-news-eg.net | Atara Biotherapeutics (ATRA) Inches Higher as Shares Test Key Resistance - Institutional Volume po-news-eg.net | View source ↗ | po-news-eg.net | Jul 21, 2026 | neutral | 0 | 0.6 |
| ATRA Forecast — Price Target — Prediction for 2027 - TradingView | ATRA Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| ATRA - Finviz | ATRA Finviz | View source ↗ | Finviz | May 27, 2026 | neutral | 0 | 0.6 |
| ATRA Stock Shoots Up 82% in a Month: Here's What You Should Know - Yahoo Finance | ATRA Stock Shoots Up 82% in a Month: Here's What You Should Know Yahoo Finance | View source ↗ | Yahoo Finance | May 21, 2026 | neutral | 0 | 0.6 |
| Atara (ATRA) Provides Update on BLA Resubmission and Financial S - GuruFocus | Atara (ATRA) Provides Update on BLA Resubmission and Financial S GuruFocus | View source ↗ | GuruFocus | May 12, 2026 | neutral | 0 | 0.6 |
| ATRA Stock Sees Biggest Single-Day Gain In Over 2 Years, Breaches Key Technical Milestone – New FDA Update Has Bulls Circling Back - Stocktwits | ATRA Stock Sees Biggest Single-Day Gain In Over 2 Years, Breaches Key Technical Milestone – New FDA Update Has Bulls Circling Back Stocktwits | View source ↗ | Stocktwits | May 7, 2026 | neutral | 0 | 0.6 |
| ATRA Stock Surges As Traders Pile Into Biotech Momentum - StocksToTrade | ATRA Stock Surges As Traders Pile Into Biotech Momentum StocksToTrade | View source ↗ | StocksToTrade | May 7, 2026 | neutral | 0 | 0.6 |
| Atara surges after FDA meeting on cell therapy (ATRA:NASDAQ) - Seeking Alpha | Atara surges after FDA meeting on cell therapy (ATRA:NASDAQ) Seeking Alpha | View source ↗ | Seeking Alpha | May 7, 2026 | neutral | 0 | 0.6 |
| FDA Resubmission Path for Tab-cel Keeps Atara’s (ATRA) Regulatory Timeline Alive - Yahoo Finance | FDA Resubmission Path for Tab-cel Keeps Atara’s (ATRA) Regulatory Timeline Alive Yahoo Finance | View source ↗ | Yahoo Finance | May 7, 2026 | neutral | 0 | 0.6 |
| FDA says single-arm study could back Atara's tab-cel refiling - Stock Titan | FDA says single-arm study could back Atara's tab-cel refiling Stock Titan | View source ↗ | Stock Titan | May 7, 2026 | neutral | 0 | 0.6 |
| Atara Biotherapeutics, Inc. (ATRA) Registers Possible Resale of 400K Common Shares Tied to HCR Warrant Exercise - Yahoo Finance | Atara Biotherapeutics, Inc. (ATRA) Registers Possible Resale of 400K Common Shares Tied to HCR Warrant Exercise Yahoo Finance | View source ↗ | Yahoo Finance | Apr 2, 2026 | neutral | 0 | 0.6 |
| Atara Biotherapeutics stock plunges after FDA rejects cancer therapy - Investing.com | Atara Biotherapeutics stock plunges after FDA rejects cancer therapy Investing.com | View source ↗ | Investing.com | Jan 12, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.